Recommended by Michael Letcher
Tracking biotech acquisition targets before big pharma strikes. Featuring acquisition targets with detailed analysis M&A probability signals and catalysts Valuation insight and deal timing estimates Big pharma strategy patterns "NOT Pro Advice"
The M&A Hunter is all over the most promising biotech and banking acquisition targets and possible valuations you could see if these companies are acquired.